AMN

SEC source: 0001209191-17-018213 · doc4.xml · nonDerivative · entry 4

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,228

SEC source: 0001209191-17-018213 · doc4.xml · nonDerivative · entry 3

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-018213 · doc4.xml · nonDerivative · entry 2

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,066

SEC source: 0001209191-17-018213 · doc4.xml · nonDerivative · entry 1

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-016172 · doc4.xml · nonDerivative · entry 2

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,176

SEC source: 0001209191-17-016172 · doc4.xml · nonDerivative · entry 1

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,176

F1 · price: The price reported in this row represents a weighted average price of $41.6002 per share. These shares were sold in multiple transactions at prices ranging from $41.60 to $41.605, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-016170 · doc4.xml · nonDerivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,119

SEC source: 0001209191-17-016170 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,199

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-014562 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,582

F1 · kind: The sale of 3,655 shares of AMN Common Stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-014967 · doc4.xml · derivative · entry 3

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,482 shares

Expires 2017-04-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-014967 · doc4.xml · nonDerivative · entry 2

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,176

SEC source: 0001209191-17-014967 · doc4.xml · nonDerivative · entry 1

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,239

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-016170 · doc4.xml · derivative · entry 3

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,482 shares

Expires 2017-04-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-066670 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,850

F1 · kind: The reporting person transferred 10,124 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-17-012989 · doc4.xml · nonDerivative · entry 8

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,542

F6 · kind: The sale of 9,634 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · price: The price reported in this row represents a weighted average price of $41.609 per share. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-012989 · doc4.xml · nonDerivative · entry 7

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,176

F5 · kind: The sale of 823 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-013547 · doc4.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001209191-17-012997 · doc4.xml · nonDerivative · entry 8

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,916

F7 · kind: The sale of 8,800 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F8 · price: The price reported in this row represents a weighted average price of $40.0105 per share. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-012997 · doc4.xml · derivative · entry 10

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,662

Underlying: Common Stock · 2,296 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F12 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year.

F11 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-17-012997 · doc4.xml · derivative · entry 9

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,969

Underlying: Common Stock · 3,058 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F10 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2015 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2015 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2016 fiscal year.

F11 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-17-012997 · doc4.xml · nonDerivative · entry 7

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,716

F5 · kind: The sale of 9,192 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · price: The price reported in this row represents a weighted average price of $40.0484 per share. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-012997 · doc4.xml · nonDerivative · entry 6

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,908

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012997 · doc4.xml · nonDerivative · entry 5

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,106

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common Stock acquired on the vesting of RSUs.

SEC source: 0001209191-17-012997 · doc4.xml · nonDerivative · entry 4

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,810

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012997 · doc4.xml · nonDerivative · entry 3

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,405

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-17-012997 · doc4.xml · nonDerivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,347

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012997 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,293

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2016 for the one-year period beginning on January 1, 2016 and ended December 31, 2016. The maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-17-012989 · doc4.xml · derivative · entry 10

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,108

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F11 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-17-012989 · doc4.xml · derivative · entry 9

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,256

Underlying: Common Stock · 2,324 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F9 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2015 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2015 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2016 fiscal year.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-17-012989 · doc4.xml · nonDerivative · entry 6

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,999

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012989 · doc4.xml · nonDerivative · entry 5

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,797

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common Stock acquired on the vesting of RSUs.

SEC source: 0001209191-17-012989 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,266

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012989 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-17-012989 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,154

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012989 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,652

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2016 for the one-year period beginning on January 1, 2016 and ended December 31, 2016. The maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-17-012993 · doc4.xml · derivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,935

Underlying: Common Stock · 58,935 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each deferred Performance Restricted Stock Unit ("PRSU") represents a contingent right to receive one share of Common stock.

F7 · derivative.exercise_date: The deferred PRSUs in this row resulted from the vesting of a PRSU award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2016 for the one-year period beginning on January 1, 2016 and ended December 31, 2016. The maximum amount of PRSUs for this award were deemed earned and vested. In 2014, the reporting person elected to defer receipt of the Common Stock underlying the deferred PRSUs set forth in this row until January 2, 2018.

F8 · derivative.expiration_date: Deferred PRSUs do not have an expiration date.

SEC source: 0001209191-17-012993 · doc4.xml · derivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,770

Underlying: Common Stock · 13,156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The RSUs identified in this row were granted on December 9, 2014 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2015 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2016 fiscal year.

F5 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-17-012993 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,017

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012993 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 337,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-17-012985 · doc4.xml · derivative · entry 9

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,662

Underlying: Common Stock · 2,296 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F9 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year.

F8 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-17-012985 · doc4.xml · derivative · entry 8

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,969

Underlying: Common Stock · 3,058 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F7 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2015 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2015 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2016 fiscal year.

F8 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-17-012985 · doc4.xml · nonDerivative · entry 7

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,237

F5 · kind: The sale of 3,249 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-012985 · doc4.xml · nonDerivative · entry 6

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,486

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012985 · doc4.xml · nonDerivative · entry 5

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common Stock acquired on the vesting of RSUs.

SEC source: 0001209191-17-012985 · doc4.xml · nonDerivative · entry 4

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,388

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012985 · doc4.xml · nonDerivative · entry 3

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-17-012985 · doc4.xml · nonDerivative · entry 2

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,925

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-17-012985 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,095

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2016 for the one-year period beginning on January 1, 2016 and ended December 31, 2016. The maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-17-006516 · doc4.xml · derivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The PRSUs set forth in this row resulted from the vesting of a PRSU award granted by the Company on January 3, 2013. On January 5, 2016, the maximum number of PRSUs that could have been earned, 80,477, were deemed earned and vested under the January 3, 2013 PRSU award.

F5 · derivative.expiration_date: PRSUs do not have an expiration date.

SEC source: 0001209191-17-006516 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,725

F2 · kind: Number of shares withheld for tax purposes.